Neutrophil-to-lymphocyte ratio in COPD flare-ups.

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center observational study enrolling adults hospitalized with acute exacerbations of COPD at the Chest Department of Ain Shams University Hospitals. Researchers will calculate the neutrophil-to-lymphocyte ratio (NLR) from routine blood counts and correlate NLR values with measures of clinical severity, adverse outcomes, and response to treatment. Patients with malignancy or hematological disorders are excluded to avoid confounding of blood counts. The study aims to determine whether NLR, an inexpensive inflammatory marker, adds prognostic information in the hospital setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged 18 and above, Patients who will be admitted at the Chest department, Ain-Shams University Hospitals, diagnosed with AECOPD based on the Global Initiative for Chronic Obstructive Lung Disease 2024 criteria

Exclusion Criteria:

* Patients who refused treatment.
* COPD patients with Malignancy, hematological disorders

Where it's running

• Ain Shams University
  Cairo, Abbasyea, Egypt Recruiting

Study contacts

• Study coordinator: Hieba G Ezzelregal, MD
• Email: hiebagamal24@med.asu.edu.eg
• Phone: 01002041611

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Non-invasive ventilation or CPAP for COPD with sleep apnea after a serious COPD flare

  This study tests whether non-invasive ventilation (NIV) or CPAP can help adults with COPD and coexisting obstructive sleep apnea after a severe COPD flare requiring hospital care.

  Recruiting Phase 3 Assistance Publique - Hôpitaux de Paris · Paris · NCT07047092

• Collecting data on COPD exacerbations in hospitalized patients

  This study is collecting health information and samples from 1,000 patients hospitalized for COPD flare-ups to help improve future treatments and understanding of the condition.

  Recruiting at 10 sites KU Leuven · Linz and 21 other locations · NCT05008081

• NAVA use in preterm neonates with respiratory distress syndrome

  This trial tests whether neurally adjusted ventilatory assist (NAVA) helps preterm babies with respiratory distress syndrome breathe more easily than conventional ventilation.

  Recruiting Ain Shams University · Cairo, Abbasia · NCT07926009

• Ruta C and Vitamin C in Sepsis: Adding antioxidants to standard care

  This trial tests whether adding Ruta C (rutin plus vitamin C) or vitamin C alone to standard sepsis treatment helps adults in the ICU stay shorter and recover better.

  Recruiting Ain Shams University · Cairo, Cairo Governorate · NCT07922213

• Left DLPFC rTMS vs iTBS for emotional dysregulation, impulsivity, and NSSI in Borderline Personality Disorder

  This trial tests whether high-frequency rTMS or intermittent theta-burst stimulation over the left DLPFC can help reduce emotional instability, impulsivity, and non-suicidal self-injury in adults with Borderline Personality Disorder.

  Recruiting Ain Shams University · Cairo, Cairo Governorate · NCT07919587

• Trimetazidine as an extra therapy for aluminum phosphide poisoning

  In this pilot trial, adults with acute aluminum phosphide poisoning receive standard care plus trimetazidine to see if it helps save lives and improve recovery.

  Recruiting Phase 3 Ain Shams University · Cairo, Abbassia · NCT07916922

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.